… personalised medicine in IPF and other ILDs comes primarily from data in other chronic lung
diseases… biomarkers that might lead to a personalised approach in future. Given these data, …

… disease. The recognition of all these prognostic and therapeutic patient subgroups lead to a
more personalised approach to … The proportional Venn diagram of obstructive lung disease: …

… Pulmonary hypertension (PH) due to lung diseases … lung diseases (ILDs) is 3.5–15% at
an early stage, 30–50% at the time of advanced disease, and 60–90% in patients listed for lung …

… to assess the application of metabolomics to lung disease, progress has been slow [54]. …
of inflammatory lung diseases, including ARDS [85, 86]. With a view to lung regeneration, …

… with lung mechanics to understand respiratory pathology at a systems level. This is significant
as this approach … have already made contributions to personalised healthcare and how the …

… This is a further example of where a personalised approach is critical in addressing the …
Matrix metalloproteases exert tissue-damaging effects in lung disease and are implicated in the …

… definitions, we propose a shift from an event-centred definition to an approach focused on
… , which might be the result of different disease mechanisms. In this proposal from the ANTES …

… in their disease progression. Below we review the ongoing quest for novel therapeutic
approaches … pulmonary disease (COPD), another chronic lung disease associated with significant …

… approaches to non-malignant respiratory disease presents exciting possibilities, and has
already led to new approaches … chronic obstructive pulmonary disease, asthma, lung fibrosis or …

… for Chronic Obstructive Lung Disease reorganised treatment … to target a personalised medicine
approach. Another challenge … the need for new treatment approaches in conjunction with …